logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Trilink Biotechnologies, Inc.


USPTO Granted Patents = 13

% Expired Patents = 7.7


Trademarks = 17

Forward Citations = 133

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Alexandre Lebedev (12 out of 12 patents)

silverMedal Richard I Hogrefe (9 out of 18 patents)

bronzeMedal Anton P McCaffrey (8 out of 8 patents)

4.  Dongwon Shin (8 out of 8 patents)

5.  Gerald Zon (3 out of 19 patents)

6.  Natasha Paul (2 out of 4 patents)

7.  Jonathan Shum (2 out of 2 patents)

8.  Sabrina Shore (1 out of 8 patents)

9.  Inna Koukhareva (1 out of 1 patent)

10.  Morteza M Vaghefi (1 out of 5 patents)

11.  Alexandre V Lebedev (1 patent)

12.  Anton P Mccaffrey (0 patent)


13 patents:

1. 12258369 - Compositions and methods for synthesizing 5'-capped RNAs (2025-03-25),
2. 12103944 - Compositions and methods for synthesizing 5'-capped RNAs (2024-10-01),
3. 11878991 - Compositions and methods for synthesizing 5′-Capped RNAs (2024-01-23),
4. 11578095 - Compositions and methods for synthesizing 5'-Capped RNAs (2023-02-14),
5. 11414453 - Compositions and methods for synthesizing 5'-capped RNAs (2022-08-16),
6. 10913768 - Compositions and methods for synthesizing 5'-capped RNAs (2021-02-09),
7. 10519189 - Compositions and methods for synthesizing 5'-Capped RNAs (2019-12-31),
8. 10494399 - Compositions and methods for synthesizing 5'-Capped RNAS (2019-12-03),
9. 9631227 - Chemically modified ligase cofactors, donors and acceptors (2017-04-25),
10. 8728725 - Chemically modified ligase cofactors, donors and acceptors (2014-05-20),
11. 8361753 - Phosphotriester-modified oligonucleotide primers for nucleic acid amplification (2013-01-29),
12. 8133669 - Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid (2012-03-13),
13. 6320041 - Pre-activated carbonyl linkers for the modification of oligonucleotides (2001-11-20),
Company Overview
Trilink Biotechnologies, Inc. is a biotechnology company based in San Diego, California, specializing in the development and manufacturing of nucleic acid products. The company focuses on providing high-quality oligonucleotides and related reagents for applications in research, diagnostics, and therapeutics. With a commitment to innovation, Trilink supports advancements in genomics, molecular biology, and personalized medicine, catering to a diverse clientele in the life sciences sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#411 in San Diego, CA

#5,661 in California

#23,854 in US

#45,081 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Trilink Biotechnologies, Inc.

Forward Citations = 133

10 inventors:

goldMedal Alexandre Lebedev (12 out of 12 patents)

silverMedal Richard I Hogrefe (9 out of 18 patents)

bronzeMedal Anton P McCaffrey (8 out of 8 patents)

4.  Dongwon Shin (8 out of 8 patents)

5.  Gerald Zon (3 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trilink Biotechnologies, Inc.. Retrieved from https://idiyas.com/company/trilink-biotechnologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…